Patient-Reported Outcomes from the Randomized Phase Iii Alex Study of Alectinib Versus Crizotinib in Patients with Alk-Positive Non-Small-Cell Lung Cancer

AuthID
 P-00R-JQY
14
Author(s)
Perol, M
·
Pavlakis, N
·
Levchenko, E
·
Platania, M
·
Chiari, R
·
Moran, T
·
Mitry, E
·
Nueesch, E
·
Liu, T
·
Balas, B
·
Konopa, K
·
Peters, S
Tipo de Documento
Article
Year published
2019
Publicado
in LUNG CANCER, ISSN: 0169-5002
Volume: 138, Páginas: 79-87 (9)
Indexing
Wos®
Google Scholar®
Publication Identifiers
Wos: WOS:000503323900012
Source Identifiers
ISSN: 0169-5002
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Info
At this moment we don't have any links to full text documens.

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service